Literature DB >> 35862720

Expression of CD117 (c-Kit) on Circulating B Cells in Pediatric Schistosomiasis.

Isaac O Onkanga1,2, Rachael Hamilton3, Pauline N M Mwinzi1, Thomas Schneider3, Bartholomew N Ondigo1,4, Huldah Sang1, Edna Ondari1, Fredrick Rawago1, Walter Jaoko2, Maurice R Odiere1, Lisa Ganley-Leal3.   

Abstract

Few B cells express CD27, the primary marker for memory B cells, in pediatric schistosomiasis, suggesting B cell malfunction. This study further demonstrates unexpected high expression of CD117 on circulating B cells in children highly exposed to Schistosoma mansoni infectious larvae. CD117 is expressed by immature or lymphoma B cells, but not by mature, circulating cells. We therefore sought to define the significance of CD117 on blood B cells. We found that CD117-positive (CD117+) B cells increased with the intensity of schistosome infection. In addition, CD117 expression was reduced on CD23+ B cells previously shown to correlate with resistance to infection. Stimulation with a panel of cytokines demonstrated that CD117 levels were upregulated in response to a combination of interleukin 4 (IL-4) and stem cell factor (SCF), the ligand for CD117, whereas IL-2 led to a reduction. In addition, stimulation with SCF generally reduced B cell activation levels. Upon further investigation, it was established that multiple circulating cells expressed increased levels of CD117, including monocytes, neutrophils, and eosinophils, and expression levels correlated with that of B cells. Finally, we identified a population of large circulating cells with features of reticulocytes. Overall, our results suggest that hyperexposure to intravascular parasitic worms elicits immature cells from the bone marrow. Levels of SCF were shown to reduce as children began to transition through puberty. The study results pose an explanation for the inability of children to develop significant immunity to infection until after puberty.

Entities:  

Keywords:  B cells; CD117; CD23; pediatric schistosomiasis; schistosomiasis

Mesh:

Substances:

Year:  2022        PMID: 35862720      PMCID: PMC9387214          DOI: 10.1128/iai.00160-22

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  60 in total

1.  Human susceptibility to Schistosoma japonicum in China correlates with antibody isotypes to native antigens.

Authors:  Y Li; A C Sleigh; A G Ross; Y Li; X Zhang; G M Williams; X Yu; M Tanner; D P McManus
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Jul-Aug       Impact factor: 2.184

2.  IL-2 requirement for human plasma cell generation: coupling differentiation and proliferation by enhancing MAPK-ERK signaling.

Authors:  Simon Le Gallou; Gersende Caron; Céline Delaloy; Delphine Rossille; Karin Tarte; Thierry Fest
Journal:  J Immunol       Date:  2012-05-25       Impact factor: 5.422

3.  Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function.

Authors:  A Muraguchi; J H Kehrl; D L Longo; D J Volkman; K A Smith; A S Fauci
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

4.  Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni.

Authors:  Carla L Black; Erick M O Muok; Pauline N M Mwinzi; Jennifer M Carter; Diana M S Karanja; W Evan Secor; Daniel G Colley
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

5.  Normal human erythrocytes express CD36, an adhesion molecule of monocytes, platelets, and endothelial cells.

Authors:  M R van Schravendijk; S M Handunnetti; J W Barnwell; R J Howard
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

6.  Schistosoma mansoni morbidity among school-aged children: a SCORE project in Kenya.

Authors:  Aaron M Samuels; Elizabeth Matey; Pauline N M Mwinzi; Ryan E Wiegand; Geoffrey Muchiri; Edmund Ireri; Molly Hyde; Susan P Montgomery; Diana M S Karanja; W Evan Secor
Journal:  Am J Trop Med Hyg       Date:  2012-09-17       Impact factor: 2.345

7.  Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.

Authors:  Adebayo J Molehin; Souad R Sennoune; Weidong Zhang; Juan U Rojo; Arif J Siddiqui; Karlie A Herrera; Laura Johnson; Justin Sudduth; Jordan May; Afzal A Siddiqui
Journal:  Parasitol Res       Date:  2017-10-12       Impact factor: 2.289

8.  Suppression of circulating IgD+CD27+ memory B cells in infants living in a malaria-endemic region of Kenya.

Authors:  Amolo S Asito; Erwan Piriou; Walter G Z O Jura; Collins Ouma; Peter S Odada; Sidney Ogola; Nancy Fiore; Rosemary Rochford
Journal:  Malar J       Date:  2011-12-13       Impact factor: 2.979

9.  Comparing parasitological vs serological determination of Schistosoma haematobium infection prevalence in preschool and primary school-aged children: implications for control programmes.

Authors:  Welcome M Wami; Norman Nausch; Katharina Bauer; Nicholas Midzi; Reggis Gwisai; Peter Simmonds; Takafira Mduluza; Mark Woolhouse; Francisca Mutapi
Journal:  Parasitology       Date:  2014-03-28       Impact factor: 3.234

Review 10.  Control of Immunoregulatory Molecules by miRNAs in T Cell Activation.

Authors:  Ana Rodríguez-Galán; Lola Fernández-Messina; Francisco Sánchez-Madrid
Journal:  Front Immunol       Date:  2018-09-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.